ALFA News
Straight from the exchange filing
Latest Pharmaceuticals stock news from NSE and BSE filings, 95 stories so far.
Anlon Healthcare reports 42.98% revenue growth in FY26 to ₹172.22 Cr. Management guides for ₹800 Cr revenue by FY28 supported by ₹130 Cr Capex and new APIs.
Gujarat Themis Biosyn Ltd announces a ₹1,000 crore fund raise through QIP and a preferential issue to non-promoters to support strategic corporate developments.
Glenmark Pharmaceuticals launches Lacosamide Injection USP in the US market, targeting annual sales of $15.2 million. Learn about this strategic portfolio expansion.
Alkem Laboratories launches India's first semaglutide single-shot pre-filled syringes starting at ₹350, expanding treatment for diabetes and obesity management.
Amanta Healthcare successfully commissions a 10.8 MWp solar plant in Gujarat for captive use. The move aims to cut energy costs and enhance sustainability.
Sai Parenterals secures a ₹104.50 crore exclusive anti-TB supply contract from PILL CORP, Philippines. The 10-year agreement provides significant revenue visibility.
Senores Pharmaceuticals reports a 108% profit surge to ₹122 Cr in FY26. Management targets 30-40% revenue growth in FY27 as US ANDA launches accelerate.
Lupin Ltd reports record FY26 revenue of ₹27,958 cr, a 23% YoY increase. US sales crossed $1.3bn while EBITDA margins hit 29.7% on complex generic launches.
Emcure Pharmaceuticals reports FY26 revenue of ₹9,204 crore, achieving 16.6% YoY growth and surpassing the $1 billion mark with strong international performance.
Shelter Pharma Ltd (543963) launches FOLIMAN Folic Acid Tablets in international markets. Explore the pharmaceutical firm's expansion into nutraceuticals today.
Lupin Limited achieves record FY26 results with 32% Q4 revenue growth and 29.7% EBITDA margins driven by US generic exclusivity and strong India chronic sales.
Kabra Drugs Ltd announces a new AI-defense R&D hub in Chennai and strategic generic pharma expansion in South India following a 578% surge in quarterly net profit.
Emcure Pharmaceuticals reports ₹9,204 Cr revenue for FY26, surpassing the $1 billion mark. Management guides for margin expansion and domestic recovery in FY27.
Auro Laboratories Ltd receives EDQM Attestation of Inspection for its MIDC Tarapur facility, confirming EU GMP compliance for Metformin Hydrochloride production.
Auro Laboratories Ltd (530233) secures Swissmedic GMP certification for its Tarapur unit, aligning with EU-Switzerland standards for therapeutic products.
